DCT

2:11-cv-01882

Celgene Corp v. Mylan Pharma Inc

General
Filed
04/01/11
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Judge
Period
PO Win Rate
--
69%
Defendant
Party
Attorney